Description

D-Myo-Inositol, 2,4,6-Tris-o-(Phenylmethyl)-, 3,5-Bisbis(Phenylmethyl) Phosphate is a high-purity, synthetically modified inositol phosphate derivative, specifically protected with benzyl groups. This compound matters as a critical advanced pharmaceutical intermediate and a versatile building block in organic synthesis, offering precise control over phosphorylation and deprotection chemistry. It is primarily needed by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical sectors for developing novel bioactive molecules and complex organic compounds.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of complex inositol phosphate analogs and phospholipids for drug discovery and development.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies related to inositol signaling pathways.
• Organic Synthesis Building Block: Serves as a protected intermediate for the controlled introduction of phosphate groups in multi-step synthetic routes.
• Agrochemical Development: Potential intermediate for creating novel plant growth regulators or targeted pesticides.
• Glycoconjugate Synthesis: Useful in the preparation of complex carbohydrate and glycophospholipid derivatives.
• Material Science: Exploration as a monomer or cross-linker for specialty polymers with unique properties.

Basic Information

Product Name	D-Myo-Inositol, 2,4,6-Tris-o-(Phenylmethyl)-, 3,5-Bisbis(Phenylmethyl) Phosphate
CAS No.	227177-04-0
Molecular Formula	C55H55O12P
Molecular Weight	939.00 g/mol
Synonyms	2,4,6-Tri-O-benzyl-myo-inositol 3,5-bis(benzyl phosphate); 1D-myo-Inositol, 2,4,6-tris-O-(phenylmethyl)-, 3,5-bis[bis(phenylmethyl) phosphate]; 3,5-Bis-O-(dibenzylphosphoryl)-1,2,4,6-tetra-O-benzyl-myo-inositol; Benzyl-Protected myo-Inositol Phosphate; Hexabenzyl myo-Inositol Diphosphate; myo-Inositol, 2,4,6-tris-O-benzyl-, 3,5-bis(dibenzyl phosphate); D-myo-Inositol-3,5-bisphosphate hexabenzyl ester
EINECS	Contact for details

Quality Control

Our D-Myo-Inositol, 2,4,6-Tris-o-(Phenylmethyl)-, 3,5-Bisbis(Phenylmethyl) Phosphate is produced under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure high chemical purity and structural integrity, consistent with standards for advanced pharmaceutical intermediates. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound is moisture-sensitive (hygroscopic); ensure the container is sealed under an inert atmosphere such as nitrogen or argon after opening to maintain stability and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder or solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.